S20-084 CDK19- Selective Inhibitors, and Methods of Use thereof Researchers at Stanford University have identified new CDK19-selective inhibitors for the treatment of triple negative breast cancer. Robert Hsieh Mark Smith Michael Clarke Vinnie Alford Andre St. Amant